Anmol Mullins

Anmol Mullins is a seasoned global commercial leader with over 17 years of experience in market access, finance, and marketing spanning various industries.

His expertise lies in developing HEOR value propositions, reimbursement strategy, new product launch, value-based pricing, and portfolio strategy.

Anmol has a strong understanding of global healthcare markets, particularly in medical devices, diagnostics, gene therapy, and pharmaceuticals market access.

He excels in building relationships with stakeholders, aligning with Senior Management, and leading global cross-functional teams to drive successful outcomes.

Anmol's specialties include market access, strategic planning, portfolio strategy, new product development, U.S. and international reimbursement, health policy, government affairs, payor relations, health economics, and health outcomes research.

He also has expertise in real-world evidence, patient-reported outcomes, pricing strategy, managed care strategy, Medicare strategy, health technology assessments, and joint advice.

Anmol Mullins is well-versed in European and Asia Pacific pharma and medical device reimbursement, patient advocacy, marketing, sales, accounting, contracting, forecasting, and budgeting.

Anmol holds a Master of Business Administration with a focus on Banking, Corporate Finance, and International Marketing, alongside a Bachelor's degree in Biology from Texas A&M University and studies in Economics from the University of Maryland College Park.

His notable roles include Global Patient Access Head at Takeda, Global Market Access Franchise Head for Genetic Diseases and Ophthalmology at Shire, and Worldwide Franchise Director for Patient Access at Novartis.

He has also held key positions at Alcon (Novartis Division), Kinetic Concepts, and American Airlines, showcasing his multifaceted experience across leading organizations in the industry.